AB
XERS icon

Amalgamated Bank’s Xeris Biopharma Holdings XERS Stock Holding History

Amalgamated Bank’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,824
Closed -$38K – 2819
2025
Q4 		$38K Sell
4,824
-10
-0.2% -$79 ﹤0.01% 1904
2025
Q3 		$39K Hold
4,834
– – ﹤0.01% 1916
2025
Q2 		$23K Hold
4,834
– – ﹤0.01% 2066
2025
Q1 		$27K Buy
4,834
+239
+5% +$965 ﹤0.01% 1973
2024
Q4 		$16K Hold
4,595
– – ﹤0.01% 2222
2024
Q3 		$13K Hold
4,595
– – ﹤0.01% 2342
2024
Q2 		$10K Hold
4,595
– – ﹤0.01% 2478
2024
Q1 		$10K Sell
4,595
-14,352
-76% -$37.1K ﹤0.01% 2467
2023
Q4 		$45K Sell
18,947
-1,367
-7% -$2.52K ﹤0.01% 2304
2023
Q3 		$38K Hold
20,314
– – ﹤0.01% 2369
2023
Q2 		$53K Buy
20,314
+1,841
+10% +$4.69K ﹤0.01% 2298
2023
Q1 		$30K Sell
18,473
-2,776
-13% -$3.48K ﹤0.01% 2507
2022
Q4 		$28K Hold
21,249
– – ﹤0.01% 2654
2022
Q3 		$33K Buy
21,249
+337
+2% +$557 ﹤0.01% 2642
2022
Q2 		$32K Buy
+20,912
New +$44.1K ﹤0.01% 2694

Other funds holding XERS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Amalgamated Bank's XERS Position: Q1 2026 in Review

Amalgamated Bank sold out of Xeris Biopharma Holdings (XERS) in Q1 2026, closing a stake of 4,824 shares — an estimated $38K sold.

Amalgamated Bank first reported a position in XERS in Q2 2022 and held it in 15 quarters. The position peaked at $53K in Q2 2023. 237 funds tracked by Wall St. Rank hold XERS as of Q1 2026.

  • Amalgamated Bank reported no remaining Xeris Biopharma Holdings position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 4,824 Xeris Biopharma Holdings shares in Q1 2026, an estimated $38K.
  • Amalgamated Bank first reported a position in Xeris Biopharma Holdings in Q2 2022 and held it in 15 quarters.
  • Amalgamated Bank's Xeris Biopharma Holdings position peaked at $53K in Q2 2023.
  • 237 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.